Previous studies suggest that VA reduces inflammation by suppressing CXCL1, a pro-inflammatory chemokine secreted from dermal white adipose tissue (dWAT), which is known to delay HF cycling, induce premature catagen transition, and promote HF miniaturization [18]. The gene discussed is CXCL1; the disease is hydrops fetalis.